AI assistant
FENNEC PHARMACEUTICALS INC. — Director's Dealing 2007
Mar 16, 2007
35599_dirs_2007-03-16_83bb9679-7a6b-4be0-9415-1eb754f3d742.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3/A — Form 3/A
Issuer: ADHEREX TECHNOLOGIES INC (AMEX:ADH)
CIK: 0001211583
Period of Report: 2007-02-21
Reporting Person: KUFE DONALD W (Director)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Options (Right to buy) | $0.28 | 2014-02-28 | Common Stock (50000) | Direct | |
| Stock Options (Right to buy) | $0.88 | 2012-12-14 | Common Stock (2500) | Direct | |
| Stock Options (Right to buy) | $1.2 | 2012-05-18 | Common Stock (1000) | Direct | |
| Stock Options (Right to buy) | $1.2 | 2012-05-18 | Common Stock (18621) | Direct | |
| Stock Options (Right to buy) | $1.2 | 2012-09-21 | Common Stock (40000) | Direct | |
| Stock Options (Right to buy) | $1.7 | 2010-05-03 | Common Stock (4000) | Direct | |
| Stock Options (Right to buy) | $2.9 | 2011-05-21 | Common Stock (4000) | Direct | |
| Stock Options (Right to buy) | $3.25 | 2011-03-01 | Common Stock (1000) | Direct | |
| Stock Options (Right to buy) | $3.25 | 2011-03-01 | Common Stock (18621) | Direct |
Footnotes
F4: This Form is being amended due to a miscalculation in the Exerciseable Date/Vesting schedule previously reported for these options.
F1: The options to which this note relates are subject to vesting in three (3) installments with one-third vesting immediately and the remaining shares vesting on the first and second anniversary of the Grant Date reported above.
F2: The options to which this note relates vest in three (3) equal installments beginning on the date reported above.
F3: The options to which this note relates vested 100% on the date reported above.
F5: Exercise price for these options are in Canadian Dollars.